In serous ovarian cancers this effect reappeared (p < 0.01; 95% CI 0.06–0.4016) and we observed a significant correlation with PR expression (p < 0.05; 95% CI 0.02307–0.3688) (Table 5). This evidence concerns the gene PGR and ovarian serous adenocarcinoma.